UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.400

Sortiert nach

Changes in clinical trials of cancer drugs in mainland China over the decade 2009–18: a systematic review

The lancet oncology, 2019-11, Vol.20 (11), p.e619-e626

2019

Link zum Volltext

Verfügbarkeit prüfen

Profile and outcome of receptor conversion in breast cancer metastases: a nation‐wide multicenter epidemiological study

International journal of cancer, 2021-02, Vol.148 (3), p.692-701

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinical development of immuno-oncology in China

The lancet oncology, 2020-08, Vol.21 (8), p.1013-1016

2020

Link zum Volltext

Verfügbarkeit prüfen

Population pharmacokinetics of the anti-PD-1 antibody camrelizumab in patients with multiple tumor types and model-informed dosing strategy

Acta pharmacologica Sinica, 2021-08, Vol.42 (8), p.1368-1375

2021

Link zum Volltext

Verfügbarkeit prüfen

Availability of anticancer biosimilars in 40 countries

The lancet oncology, 2020-02, Vol.21 (2), p.197-201

2020

Link zum Volltext

Verfügbarkeit prüfen

Assessing early changes in plasma HER2 levels is useful for predicting therapeutic response in advanced breast cancer: A multicenter, prospective, noninterventional clinical study

Cancer medicine (Malden, MA), 2023-03, Vol.12 (5), p.5323-5333

2023

Link zum Volltext

Verfügbarkeit prüfen

Expression dynamics of periodic transcripts during cancer cell cycle progression and their correlation with anticancer drug sensitivity

Military medical research, 2022-12, Vol.9 (1), p.71-71, Article 71

2022

Link zum Volltext

Verfügbarkeit prüfen

Impact of coronavirus disease 2019 on the clinical diagnosis and treatment of breast cancer in China

Chinese medical journal, 2021-03, Vol.134 (5), p.590-592

2021

Link zum Volltext

Verfügbarkeit prüfen

Molecular subtypes predict the preferential site of distant metastasis in advanced breast cancer: a nationwide retrospective study

Frontiers in oncology, 2023-01, Vol.13, p.978985-978985

2023

Link zum Volltext

Verfügbarkeit prüfen

Association of HER2 status with prognosis in gastric cancer patients undergoing R0 resection: A large-scale multicenter study in China

World journal of gastroenterology : WJG, 2016-06, Vol.22 (23), p.5406-5414

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinical characteristic and management of HER-2 positive node negative small tumor breast cancer (pT1abN0)

Zhong hua yi xue za zhi, 2013-01, Vol.93 (2), p.81-83

2013

Link zum Volltext

Verfügbarkeit prüfen

Hormonal therapy might be a better choice as maintenance treatment than capecitabine after response to first-line capecitabine-based combination chemotherapy for patients with hormone receptor-positive and HER2-negative,metastatic breast cancer

Ai zheng, 2016-04, Vol.35 (6), p.46-52, Article 39

2016

Link zum Volltext

Verfügbarkeit prüfen

Switching to anastrozole plus goserelin vs continued tamoxifen for adjuvant therapy of premenopausal early-stage breast cancer: preliminary results from a randomized trial

Cancer management and research, 2019-01, Vol.11, p.299-307

2019

Link zum Volltext

Verfügbarkeit prüfen

Molecular subtypes and individualized treatment of breast cancer

Zhōnghuá zhŏngliú zázhì, 2010-09, Vol.32 (9), p.641

2010

Link zum Volltext

Verfügbarkeit prüfen

Retrospect and prospect of endocrine therapy for hormone receptor positive advanced breast cancer patients

Zhong hua yi xue za zhi, 2012-05, Vol.92 (19), p.1297-1299

2012

Link zum Volltext

Verfügbarkeit prüfen

Association of genetic variantions of circadian clock genes and risk of breast cancer

Zhōnghuá zhŏngliú zázhì, 2013-03, Vol.35 (3), p.236

2013

Link zum Volltext

Verfügbarkeit prüfen

Prognostic factors and adjuvant systemic therapy for patients with HER2-positive T1N0 breast cancer: evidence from a real-world study with long-term follow-up

Breast cancer research and treatment, 2023-02, Vol.197 (3), p.569-582

2023

Link zum Volltext

Verfügbarkeit prüfen

Clinical features and treatment strategies of older patients with breast cancer

Zhongguo Zhong xi yi jie he za zhi, 2008-10, Vol.28 (10), p.874

Xu, Bing-He

2008

Link zum Volltext

Verfügbarkeit prüfen

Combined analysis of receptor expression reflects inter-and intra-tumor heterogeneity in HR+/HER2+ breast cancer

Breast cancer research and treatment, 2022-07, Vol.194 (2), p.221-230

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases

Zhōnghuá zhŏngliú zázhì, 2013-03, Vol.35 (3), p.207

2013

Link zum Volltext

Verfügbarkeit prüfen

Advances and perspective in clinical research on breast cancer

Zhōnghuá zhŏngliú zázhì, 2007-12, Vol.29 (12), p.881

Xu, Bing-He

2007

Link zum Volltext

Verfügbarkeit prüfen

Prognostic factors and analyses of different therapeutic strategies in HR+ breast cancer patients with bone-only metastases

Zhong hua yi xue za zhi, 2012-12, Vol.92 (46), p.3279-3282

2012

Link zum Volltext

Verfügbarkeit prüfen

Clinical analysis of 34 patients with adrenal metastasis from breast cancer

Zhōnghuá zhŏngliú zázhì, 2013-11, Vol.35 (11), p.855

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.400

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.039)
Mit Volltextzugriff
(1.334)

Publikationsform

Sprache

Englisch
(1.231)
Chinesisch
(91)
Koreanisch
(84)
Japanisch
(55)

Erscheinungsjahr

n.n

Thema

Science & Technology
(628)
Humans
(260)
Life Sciences & Biomedicine
(228)
Physical Sciences
(215)
Science & Technology - Other Topics
(209)
Multidisciplinary Sciences
(189)
Technology
(169)
Female
(160)
Biology And Life Sciences
(104)
Middle Aged
(101)
Male
(100)
Animals
(91)
Nanoparticles
(88)
Adult
(86)
Chemistry
(84)
Aged
(83)
Medicine And Health Sciences
(83)
Research And Analysis Methods
(78)
Computer Science
(71)
Algorithms
(67)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(15)

Menü

Weitere Dienste

Einstellungen

Changes in clinical trials of cancer drugs in mainland China over the decade 2009–18: a systematic review

Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial

Profile and outcome of receptor conversion in breast cancer metastases: a nation‐wide multicenter epidemiological study

Clinical development of immuno-oncology in China

Population pharmacokinetics of the anti-PD-1 antibody camrelizumab in patients with multiple tumor types and model-informed dosing strategy

Availability of anticancer biosimilars in 40 countries

Assessing early changes in plasma HER2 levels is useful for predicting therapeutic response in advanced breast cancer: A multicenter, prospective, noninterventional clinical study

Expression dynamics of periodic transcripts during cancer cell cycle progression and their correlation with anticancer drug sensitivity

Impact of coronavirus disease 2019 on the clinical diagnosis and treatment of breast cancer in China

Molecular subtypes predict the preferential site of distant metastasis in advanced breast cancer: a nationwide retrospective study

Association of HER2 status with prognosis in gastric cancer patients undergoing R0 resection: A large-scale multicenter study in China

Clinical characteristic and management of HER-2 positive node negative small tumor breast cancer (pT1abN0)

Hormonal therapy might be a better choice as maintenance treatment than capecitabine after response to first-line capecitabine-based combination chemotherapy for patients with hormone receptor-positive and HER2-negative,metastatic breast cancer

Switching to anastrozole plus goserelin vs continued tamoxifen for adjuvant therapy of premenopausal early-stage breast cancer: preliminary results from a randomized trial

Comparisons of Treatment for HER2-Positive Breast Cancer between Chinese and International Practice: A Nationwide Multicenter Epidemiological Study from China

Molecular subtypes and individualized treatment of breast cancer

Retrospect and prospect of endocrine therapy for hormone receptor positive advanced breast cancer patients

Association of genetic variantions of circadian clock genes and risk of breast cancer

Prognostic factors and adjuvant systemic therapy for patients with HER2-positive T1N0 breast cancer: evidence from a real-world study with long-term follow-up

Clinical features and treatment strategies of older patients with breast cancer

Combined analysis of receptor expression reflects inter-and intra-tumor heterogeneity in HR+/HER2+ breast cancer

Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases

Advances and perspective in clinical research on breast cancer

Prognostic factors and analyses of different therapeutic strategies in HR+ breast cancer patients with bone-only metastases

Clinical analysis of 34 patients with adrenal metastasis from breast cancer

Suchergebnisse filtern